Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients

Clinical Microbiology and Infection

Volumn 13, Issue 9, 2007, Pages 915-922

  Ang, C W ^a,b   Krogfelt, K ^c   Herbrink, P ^b   Keijser, J ^b   Van Pelt, W ^d   Dalby, T ^c   Kuijf, M ^e   Jacobs, B C ^e   Bergman, M P ^e   Schiellerup, P ^c   Visser, C E ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c STATENS SERUM INSTITUT   (Denmark)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arthritis; Campylobacter infections; Diagnosis; ELISA; Guillain Barr syndrome; Joint pain

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; CAMPYLOBACTER; CHILD; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES CULTURE; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROLOGY;

CAMPYLOBACTER;

EID: 34547837352     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01765.x     Document Type: Article

References (27)

1. Wheeler JG, Sethi D, Cowden JM et al. Study of infectious intestinal disease in England: Rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ 1999; 318: 1046-1050.
2. De Wit MA, Koopmans MP, Kortbeek LM et al. Etiology of gastroenteritis in sentinel general practices in The Netherlands. Clin Infect Dis 2001; 33: 280-288.
3. Havelaar AH, De Wit MA, Van Koningsveld R, Van Kempen E. Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol Infect 2000; 125: 505-522.
4. Hill Gaston JS, Lillicrap MS. Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol 2003; 17: 219-239.
5. Leirisalo-Repo M, Hannu T, Mattila L. Microbial factors in spondyloarthropathies: Insights from population studies. Curr Opin Rheumatol 2003; 15: 408-412.
6. Locht H, Krogfelt KA. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni / coli and enterotoxigenic Escherichia coli. Ann Rheum Dis 2002; 61: 448-452.
7. Jones DM, Eldridge J, Dale B. Serological response to Campylobacter jejuni / coli infection. J Clin Pathol 1980; 33: 767-769.
8. Nachamkin I, Hart AM. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J Clin Microbiol 1985; 21: 33-38.
9. Walder M, Forsgren A. Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application. Acta Pathol Microbiol Immunol Scand [B] 1982; 90: 423-433.
10. Oosterom J, Den Uyl CH, Banffer JR et al. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the detection of Campylobacter jejuni antibodies, and comparison with a complement fixation test (CFT). Ant V Leeuw 1985; 51: 321-331.
11. Schmidt-Ott R, Brass F, Scholz C, Werner C, Gross U. Improved serodiagnosis of Campylobacter jejuni infections using recombinant antigens. J Med Microbiol 2005; 54: 761-767.
12. Fendler C, Laitko S, Sorensen H et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001; 60: 337-343.
13. Koga M, Yuki N, Takahashi M, Saito K, Hirata K. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barréand Fisher's syndromes. J Neuroimmunol 1998; 81: 138-143.
14. Strid MA, Engberg J, Larsen LB et al. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin Diagn Lab Immunol 2001; 8: 314-319.
15. Ang CW, Laman JD, Willison HJ et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barréand Miller Fisher patients. Infect Immun 2002; 70: 1202-1208.
16. De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: A population-based approach. Epidemiol Infect 1998; 121: 637-643.
17. Mills SD, Bradbury WC, Penner JL. Isolation and characterization of a common antigen in Campylobacter jejuni and Campylobacter coli. J Clin Microbiol 1986; 24: 69-75.
18. Herbrink P, Van den Munckhof HA, Bumkens M, Lindeman J, Van Dijk WC. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988; 7: 388-393.
19. Van Loon AM, Heessen FW, Van der Logt JT, Van der Veen J. Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus. J Clin Microbiol 1981; 13: 416-422.
20. Mishu B, Ilyas AA, Koski CL et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barrésyndrome. Ann Intern Med 1993; 118: 947-953.
21. Schmidt-Ott R, Schmidt H, Feldmann S et al. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barrésyndrome. Clin Vaccine Immunol 2006; 13: 779-783.
22. Cawthraw SA, Feldman RA, Sayers AR, Newell DG. Long-term antibody responses following human infection with Campylobacter jejuni. Clin Exp Immunol 2002; 130: 101-106.
23. Taylor BV, Williamson J, Luck J et al. Sensitivity and specificity of serology in determining recent acute Campylobacter infection. Intern Med J 2004; 34: 250-258.
24. Kaldor J, Pritchard H, Serpell A, Metcalf W. Serum antibodies in Campylobacter enteritis. J Clin Microbiol 1983; 18: 1-4.
25. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barrésyndrome. N Engl J Med 1995; 333: 1374-1379.
26. Takahashi M, Koga M, Yokoyama K, Yuki N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barréand Fisher syndromes in Japan. J Clin Microbiol 2005; 43: 335-339.
27. Ang CW, Jacobs BC, Laman JD. The Guillain-Barrésyndrome: A true case of molecular mimicry. Trends Immunol 2004; 25: 61-66.